0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Hepatology

Buy Now

Hepatitis C Virus: The Next Epidemic, An issue of Gastroenterology Clinics of North America, Volume 44-4 (Hardcover) Loot Price: R1,796
Discovery Miles 17 960
Hepatitis C Virus: The Next Epidemic, An issue of Gastroenterology Clinics of North America, Volume 44-4 (Hardcover): K....

Hepatitis C Virus: The Next Epidemic, An issue of Gastroenterology Clinics of North America, Volume 44-4 (Hardcover)

K. Rajender Reddy

Series: The Clinics: Internal Medicine

 (sign in to rate)
Loot Price R1,796 Discovery Miles 17 960 | Repayment Terms: R168 pm x 12*

Bookmark and Share

Expected to ship within 12 - 19 working days

There are over 180 million people with chronic HCV infection worldwide with between 2.7 and 3.9 million in the United States. Hepatitis C most significantly affects Asia and Africa, with rates up to 15% in countries such as Egypt and up to 30% in certain regions such as Punjab, Pakistan. Hepatitis C places a significant burden on the public health infrastructure, as it remains the leading cause of chronic liver disease, accounting for 50-75% of primary liver cancers and is responsible for 30% of all liver transplantations. It is estimated to have cost the United States $5.5 billion in 1997, comparable to the national cost of asthma, $5.8 billion in 1994.This number is only expected to grow as the current HCV population ages, increasing overall rates of compensated cirrhosis/end-stage liver disease. The evolution of directly acting anti-virals has ushered in a new era for chronic hepatitis C. Ongoing drug development strategy has involved targeting several replication steps of the virus and the hope is to see all oral therapies by late 2014 or early 2015. Thus we are at an exciting cross roads with regard to new information and challenges with HCV: rising disease burden with associated high costs, the challenges globally and in multiple patient populations, and the impending availability of effective and well tolerated treatments. Therefore there is a need to commission an exclusive issue of GCNA for HCV.

General

Imprint: Elsevier - Health Sciences Division
Country of origin: United States
Series: The Clinics: Internal Medicine
Release date: December 2015
Authors: K. Rajender Reddy
Format: Hardcover
ISBN-13: 978-0-323-40248-4
Categories: Books > Medicine > Clinical & internal medicine > Hepatology
Promotions
LSN: 0-323-40248-8
Barcode: 9780323402484

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

You might also like..

Drug Hepatotoxicity, An Issue of Clinics…
Vinod Rustgi Hardcover R2,264 Discovery Miles 22 640
Advances in Cholestatic Liver Diseases…
Cynthia Levy Hardcover R1,795 Discovery Miles 17 950
Drug-Induced Liver Injury, Volume 85
Anup Ramachandran, Hartmut Jaeschke Hardcover R6,960 R5,822 Discovery Miles 58 220
Liver Cirrhosis - Debates and Current…
Georgios Tsoulfas Hardcover R3,334 Discovery Miles 33 340
Hepatitis A and Other Associated…
Costin Teodor Streba, Cristin Constantin Vere, … Hardcover R3,323 Discovery Miles 33 230
Liver Research and Clinical Management
Luis Rodrigo Hardcover R3,360 Discovery Miles 33 600
Primary Biliary Cholangitis , An Issue…
Binu V John Hardcover R2,156 Discovery Miles 21 560
Hepatobiliary Imaging, An Issue of…
Benjamin M. Yeh, Frank H. Miller Hardcover R2,770 Discovery Miles 27 700
Liver Pathophysiology - Therapies and…
Pablo Muriel Hardcover R3,934 Discovery Miles 39 340
Nonalcoholic Fatty Liver Disease - An…
Emad Hamdy Gad Hardcover R3,321 Discovery Miles 33 210
Complexities in Liver Transplantation
Dylan Long Hardcover R2,595 R2,363 Discovery Miles 23 630
Portal Hypertension - Recent Advances
Xingshun Qi Hardcover R3,311 Discovery Miles 33 110

See more

Partners